Literature DB >> 10605479

[Local corticosteroid therapy in dermatology].

O Chosidow1, B Lebrun-Vignes, I Bourgault-Villada.   

Abstract

UNLABELLED: FOUR LEVELS OF ACTION: The introduction of dermocorticosteroids (corticosteroids for topical application) has revolutionized management of many skin diseases. Depending on their antiinflammatory action, these products can be classed into four levels of action. Dermocorticosteroids have antiinflammatory, vasoconstrictor, antiproliferative, antisynthetic and immunosuppressive actions. SKIN PENETRATION: Penetration depends on the intrinsic characteristics of the drug, but also on many other factors including the nature of the excipient, additives, occlusion, localization, nature of the treated skin disease, and patient age. There is a reservoir effect, explaining why a single application is effective for dermatoses with a normal keratin layer. INDICATIONS AND CONTRAINDICATIONS: Dermocorticosteroids can be indicated in numerous inflammatory skin diseases (psoriasis, eczema ...). They are formally contraindicated in case of skin infections, diaper rash, acne and rosacea. Contact allergies have been reported. IN PRACTICE: The choice of a dermatocorticosteroid depends on the suspected sensitivity of the disease to treat, its degree of extension, and its localization as well as the patient's age and the planned duration of treatment. Cremes provide good cosmetic satisfaction. The number of tubes to be used must be strictly controlled. Occlusion is indicated in case of palmo-plantar or the scalp involvement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10605479

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  1 in total

1.  Efficacy of Traditional Medicine Product Henna and Hydrocortisone on Diaper Dermatitis in Infants.

Authors:  Abdollah Keshavarz; Ali Akbar Zeinaloo; Manoochehr Mahram; Navid Mohammadi; Omid Sadeghpour; Mohammad Reza Maleki
Journal:  Iran Red Crescent Med J       Date:  2016-02-22       Impact factor: 0.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.